Skip to main content
. Author manuscript; available in PMC: 2014 Aug 20.
Published in final edited form as: J Pharm Biomed Anal. 2008 Aug 29;48(4):1174–1180. doi: 10.1016/j.jpba.2008.08.024

Figure 3.

Figure 3

Plasma trough levels (ng/ml) for 17α-hydroxyprogesterone caproate, 17α-hydroxyprogesterone and progesterone from 18 pregnant women following intramuscular administration of 250 mg 17α-hydroxyprogesterone caproate. The patient received at least 5 weekly injections prior to sampling. (◆) 17α-hydroxyprogesterone caproate, (●) 17α-hydroxyprogesterone and (■) progesterone.